Neoplasms, Endometrial Withdrawn Phase Trials for Ponatinib (DB08901)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01888562Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial CarcinomaTreatment